These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis. Jaiswal A; Sharma RP; Garg AP Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857 [TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. Gupta AK J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137 [TBL] [Abstract][Full Text] [Related]
4. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666 [TBL] [Abstract][Full Text] [Related]
5. Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action. Rosen T; Stein Gold LF Semin Cutan Med Surg; 2016 Mar; 35(3 Suppl 3):S51-5. PubMed ID: 27074700 [TBL] [Abstract][Full Text] [Related]
6. Therapies for the treatment of onychomycosis. Gupta AK; Paquet M; Simpson FC Clin Dermatol; 2013; 31(5):544-54. PubMed ID: 24079583 [TBL] [Abstract][Full Text] [Related]
7. Onychomycosis: Diagnosis and management. Singal A; Khanna D Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. Gupta AK; Gregurek-Novak T Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230 [TBL] [Abstract][Full Text] [Related]
9. Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections. Seidl HP; Jäckel A; Müller J; Schaller M; Borelli C; Polak A Mycoses; 2015 Oct; 58(10):610-9. PubMed ID: 26334024 [TBL] [Abstract][Full Text] [Related]
10. Toenail onychomycosis: current and future treatment options. Finch JJ; Warshaw EM Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258 [TBL] [Abstract][Full Text] [Related]
11. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents. Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639 [TBL] [Abstract][Full Text] [Related]
12. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis. Gupta AK J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408 [TBL] [Abstract][Full Text] [Related]
13. Terbinafine: a review of its use in onychomycosis in adults. Darkes MJ; Scott LJ; Goa KL Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372 [TBL] [Abstract][Full Text] [Related]